Protagonist Stock 120%, Fund Outlook and Exit Signals
A hedge fund's sizable exit from Protagonist Therapeutics highlights how insiders and funds shape biotech stock moves...
Budget alignment ensures every dollar spent serves your priorities, keeping resources directed toward meaningful gains.
21,186 articlesA hedge fund's sizable exit from Protagonist Therapeutics highlights how insiders and funds shape biotech stock moves...
Eli Lilly unveils a landmark $2.8 billion cash deal to acquire Atai Beckley, aiming to push a DMT-like therapy for tr...
In today’s Morning Minute, Circle earnings take center stage as crypto markets rally. Stablecoins anchor liquidity wh...
A wave of mid contract terminations by hospital systems is reshaping Medicare Advantage. Investors and patients confr...
Merck stock jumps on a major restructuring, but Reddit sentiment shows growing skepticism as investors weigh Keytruda...
As volatility expectations shift in mid-2026, a changing VIX futures curve could compress SVOL’s monthly distribution...
CoreCivic has faced a share-price headwind even as revenue climbs. A notable $5 million stake by Hahn Capital signals...
A closer look at Janus Henderson's CLO ETFs shows a safety-first anchor in JAAA and a bolder, higher-yield challenger...
BITW fell 22.4% year-to-date through Feb. 25, 2026, tracking Bitcoin's drop and highlighting how diversification acro...
As AI partnerships captivate the market, UiPath shares edged higher amid broader tech weakness. This look at stock ma...
Morgan Stanley signals a landmark shift by planning direct Bitcoin custody and trading within its platform, edging cr...
Trump Media plans a rapid data feed of Truth Social posts for market participants, a move that could reshape timing i...